CD28 and hepatocellular carcinoma: The study reveals that both generations of c-MET-specific CAR-T cells, bearing intracellular domains of 4-1BB or CD28, stably expressed on T cell membranes, effectively target c-MET+ HCC cells in vitro and in vivo.